Caliber Imaging & Diagnostics announced that the company's VivaScope cellular imaging system will be featured at the 1st Latin American Congress of Dermoscopy on October 17-18, 2013 in Sao Paulo, Brazil. The FDA-cleared VivaScope devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties. Caliber I.D.'s Brazilian distribution partner, Emdutos is set to exhibit at the conference and will provide live demonstrations of the VivaScope 3000 portable handheld confocal microscope, which has been designed to provide access to imaging lesions in areas of the body, such as eyes, ears and scalp-or anywhere else on the body-that are not easily reached with other confocal devices.
Caliber Imaging & Diagnostics, Inc.
Equities
LCDX
US13001C1053
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
2022 | VivaScope GmbH signed a definitive agreement to acquire Caliber Imaging & Diagnostics, Inc.. | CI |
2021 | Saudi PIF nearly triples U.S. stock holdings; adds Walmart, Pinterest | RE |
1st Jan change | Capi. | |
---|---|---|
0.00% | 857 | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- LCDX Stock
- News Caliber Imaging & Diagnostics, Inc.
- Caliber Imaging & Diagnostics Introduces VivaScope 3000 Cellular Imaging System